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Summary
Dendritic cells (DC) are often arranged in planar layers in tissues with
high antigenic exposure, such as skin and mucosae. Providing an en face
view, this arrangement optimizes in situ analysis regarding morphology
(even of individual dendrites), topographic distribution (regular/clustered)
and quantiﬁcation. The few reports on human genital DC usually utilize
single markers and conventional sections, restricting immunolabelling
only to cell parts sectioned by the cut. To better assess DC in situ, we
labelled epithelial sheets, prepared from fresh cervix biopsies, with antibodies to major histocompatibility complex (MHC)-CII, CD1a and Lang
erin, revealing (with each of these markers) a dense DC network in a
planar-like, regular distribution. Using the hybrid capture system to detect
the high-risk mucotropic human papilloma virus (HPV) group, 16 posit
ive and ﬁve negative women were studied and the results were compared
between these groups. DC frequency per area was substantially reduced
(to � 50% for the three markers) in samples from all HPV-infected
patients compared with samples from controls. Unlike HPV– samples,
Langerin+ DC in HPV+ cervix exhibited a highly accentuated dendritic
appearance. We believe this to be the ﬁrst study using these three DCrestricted markers (Langerin, CD1a and MHC-CII) in cervical epithelial
sheets from high-risk HPV+ donors and also the ﬁrst study to demon
strate the morphological and quantitative changes triggered by high-risk
HPV infection. Cervical DC reduction in early, premalignant high-risk
HPV infection might represent viral subversion strategies interfering with
efﬁcient antigen handling by the immune system’s peripheral sentinels,
the DC, perhaps hampering appropriate recruitment and subsequent
development of effector (cytotoxic) T cells.

Introduction
Dendritic cells (DC) constitute a system of highly special
ized antigen presenting cells (APC) that function as senti
nel posts of the immune system, especially in peripheral
non lymphoid tissues that have a high antigenic exposure,
such as the skin and mucosae.1 Under stimuli of diverse

origin (e.g. microbial, inﬂammatory or cytokines), DC are
induced to migrate from their peripheral locations into
the nearest lymphoid tissues where they will usually local
ize in the T cell areas.2,3 It is now clear that, apart from
the original antigen (Ag) or inﬂammatory stimuli, signals
like chemokines and chemokine receptors will function to
facilitate and guide DC trafﬁcking.4 This complex process

Abbreviations: Ab, antibody; Ag, antigen; APC, antigen presenting cell; CIN, cervical intraepithelial neoplasia; CTL, cytotoxic
T lymphocyte; DAB, diaminobenzidine; DC, dendritic cell; HPV, human papilloma virus; mAb, monoclonal antibody;
MHC, major histocompatibility complex; RLU, relative light units; SS, saline solution; TZ, transformation zone.

culminates in the appropriate delivery of processed Ag to
lymphocytes and the initiation of efﬁcient immune
responses. As T cells need Ag transportation and process
ing, their dependence on DC is an absolute requirement
to efﬁciently initiate their functions as effector cells,
and this holds for both CD4+ and CD8+ (cytotoxic) T
lymphocytes.5
Although DC have been described in the human female
genital tract, especially in the cervix, these reports are scarce
regarding healthy samples and are at least contradictory
concerning human papilloma virus (HPV) infected tissues.
Some researchers have found no changes, some have repor
ted an increased DC frequency, while others have found
decreased DC numbers.6–8 This might be explained by the
fact that the samples used may have been from HPV infec
ted subjects at different stages of the disease, or taken from
different histological areas in each person.
Potential subversion strategies of micro organisms to
evade effector T cell responses could be either to attack
the T cells directly (human immunodeﬁciency virus, for
instance), or to interfere with the APC (like Mycobacte
rium tuberculosis),9 on which T cell responses are strictly
dependent.
Human cervical cancer is the ﬁrst recognized by the
World Health Organization (WHO) as being 100% attrib
utable to an infectious agent, the high risk HPV.10,11
More than 80% of the cases of this neoplasia occur in
developing countries where good programmes for screen
ing, prevention or treatment are still awaiting implemen
tation. Nevertheless, excellent research, over a time period
of 10 20 years, has been carried out on several aspects of
this malignancy, including the clinical evolution and the
classiﬁcations of this protracted disease; likewise, the
complete genomes of many HPVs are known.12,13
There are, however, gaps in the understanding of this
cancer of infectious origin and the potential interactions
with the local immune system in the female genital tract.
For instance, by necessity, most patients with cervical
cancer are ﬁrst seen and investigated when the disease has
already evolved to a neoplastic stage, and perhaps this has
made the research in the early phases of the HPV infec
tion less abundant.
Likewise, studies of regional immune responses in the
healthy, intact human female genital tract are rather scarce.
Although it is assumed that HPV enters through micro
abrasions and infects basal epithelial stem cells using mech
anisms and molecules not yet elucidated,14 the type of
immune responses (if any) occurring locally in the affected
tissues during the early phases of HPV infection are virtu
ally unknown. Moreover, it seems that there is a poor
inﬂammatory response under HPV infection during the
early cervical intraepithelial neoplasia (CIN) phases.10,11
At a systemic level it is known that antibodies (Abs)
can be induced to L1 or to E7 viral proteins. However, in
the case of L1, Abs might take months or years to

appear,10 while antibodies to E7 are uncommon before
the onset of the invasive disease, despite the fact that E7
protein might have been expressed during the previous 10
or 20 years. In any case, however, these Ab responses are
clearly non protective because the disease continues to
develop.15
Cellular immunity to HPV, as assessed mainly by in vitro
T cell reactivity, has been more difﬁcult to demonstrate,
and reports are contradictory.10 However, despite the infec
tious origin of this neoplasia, and despite the chronicity of
the infection, it seems that the cytotoxic T lymphocytes
(CTL) of a substantial proportion of women have been
found to be unresponsive to HPV.7 Faulty local (epithelial)
Ag handling and processing has been proposed to account
for this.10 There is one report, nonetheless, indicating that
delayed type hypersensitivity (DTH) to E7 correlates well
with the resolution of CIN.16
At least part of the seemingly faulty (humoral and
cellular) immune responses towards HPV might be
explained by the fact that HPV infects basal epithelial
stem cells, but for replication it apparently requires that
these cells undergo differentiation. During differentiation,
these cells transit from the basal cellular stratum towards
the lumenal (external) side where the mature virions are
ﬁnally produced and released. Moreover, HPV does not
have a lytic phase; rather, it seems to induce cell prolifer
ation, thus lacking a viraemic stage during the infection,
when dissemination and presentation of viral Ags would
occur.17 Therefore, both systemically and in the local
infected tissue, no or scarce possibilities of useful contacts
exist between the HPV and the elements of the immune
system.10,17
In an attempt to initiate in situ studies on the regional
immune responses during the early stages of human
female infection with high risk HPV, we selected two
groups of Mexican women. This segregation was based on
several, carefully evaluated, criteria, including a specialized
clinical examination, laboratory tests, cytopathology, and
the positivity or negativity for a set of high risk HPV,
according to the hybrid capture method. Epithelial sheets
from fresh cervical biopsies from these women were eval
uated for the presence, phenotype and frequency of DC,
using three well established DC markers.

Materials and methods
Selection of patients and control subjects
The protocol for this study was ﬁrst reviewed and
approved by the local ethical board of the Regional Hos
pital of Pachuca, Mexico’s Health Secretariat, Hidalgo
state. Non pregnant women who, during a period of
13 months (2001 02), were referred for a colposcopic
evaluation to the specialized gynecological services at the
Regional Hospital because of an abnormal Pap smear,

were considered for enrolment in the study. These women
were carefully evaluated, which involved undertaking a
complete gynaecological examination, including colpo
scopy, cytobrush, Pap smear and aceto white testing.
Only those women who, by all criteria, were categorized
as having low grade disease (CIN I) and with lesions large
enough to provide biopsies, were considered, asked to
participate in the study and requested to provide written,
informed consent. CIN I was chosen because is an early
premalignant lesion, usually in the so called transforma
tion zone (TZ) of the cervix, and associated with manifes
tations of HPV infection, such as koilocytosis. Of a total
of 796 women attending the ﬁrst visit to this service dur
ing the period of October 2001 to October 2002, 23 were
preselected on the basis of the results of the clinical evalu
ations mentioned above. Of these, after the clinical, labor
atory and histopathology evaluations, 16 were selected on
the basis of their positivity for high risk HPV, according
to the results obtained following analysis by the hybrid
capture system kit (Digene, Gaithersburg, MD). Five
women, undergoing hysterectomy for benign conditions,
were included as controls, according to negative results
when analysed by the criteria listed above, including gyn
ecological evaluations, the cytology results and the hybrid
capture system kit. A further step was included in which
the data of the selected patients were analysed by an
expert pathologist at the hospital.

Immunohistochemistry of conventional tissue sections
of cervix (HPV– and HPV+ samples)
Cervical biopsies were taken from the TZ in CIN I
patients and from equivalent areas in control (hysterec
tomy) women. Samples were then placed in sterile Eppen
dorf vials (Eppendorf North America, New York, NY,
USA) with 500 ll of endotoxin free sterile saline solution
(SS) and maintained on ice until use; a small piece was
then cut and placed in tissue tek (Sakura Finetek, Tor
rence, CA, USA) and kept frozen at )70� until immuno
labelling procedures took place. Once 5 lm tissue
sections had been prepared, ﬁxed with cold acetone for
7 min, and blocked with Universal Blocking Solution
(BioGenes, San Ramon, CA), primary Abs were used at
optimal dilutions, which were previously determined. Ab
to MHC CII (DR) (Dako, Carpinteria, CA) was used at a
dilution of 1 : 50, and Ab to L1 (Pharmingen, San Diego,
CA) was used at a dilution of 1 : 50. This Ab recognizes
L1 from HPV16, although it may cross react with HPV
33, but not with HVP 6 or HPV 11. Both Abs were left
to react overnight at 4�. After thorough washing of the
sections, procedures were then exactly the same as for
epithelial sheets undergoing immunohistochemistry. A
secondary Ab, peroxidase conjugated horse anti mouse
immunoglobulin (Vector, Burlingame, CA), was added in
a 50 ll volume and incubated at room temperature for

1 hr; after three more washes, bound Abs were revealed
using diaminobenzidine (DAB) as chromogen, observed
as a dark brown colour. The reaction was stopped by
washing in running water, mounting media was added
and the slides were coverslipped before analysis.

Preparation of epithelial sheets from human cervix
Once the biopsies were taken, they were placed in a sterile
Eppendorf vial containing 500 ll of endotoxin free sterile
SS, and placed on ice until their preparation in the laborat
ory, which usually took less than 3 hr. Once in the laborat
ory, samples were cut into two main portions; the smallest
was placed in tissue tek and frozen until sectioning for
immunohistochemistry, as described below, while the lar
gest portion was placed, lumen side up, in an enzymatic
cocktail containing collagenase dispase, for 15 20 min at
30�. After this incubation period, the epithelial layer was
separated by gentle traction with ﬁne forceps, stretched
very carefully and washed three times in sterile SS contain
ing 1% bovine serum albumin (SS + 1% BSA), ﬁxed in 2%
paraformaldehyde for 20 min and then washed extensively
before initiating the immunohistochemistry procedures.

Immunohistochemistry of cervical epithelial layers
to assess DC in situ
Each epithelial layer was divided into small pieces in
order to have at least three portions for testing each Ab.
The following monoclonal antibodies (mAbs) were used:
anti DR (Dako) at a dilution of 1 : 50; anti CD1a (Dako)
at a dilution of 1 : 50; and anti Langerin (LIR, Dardilly,
France) at a dilution of 1 : 50. For each set of experi
ments, an isotype matched, irrelevant control Ab was also
included. These Abs were applied overnight at 4�, in a
ﬁnal volume of 50 ll per well, for each set of cervical epi
thelial sheets. Then, epithelial sheets were washed three
times in SS + 1% BSA, and secondary Ab (peroxidase
conjugated horse anti mouse immunoglobulin) (Vector,
Burlingame, CA) was added in 50 ll of SS + 1% BSA
and incubated at room temperature for 1 hr. After wash
ing three times in SS + 1% BSA, bound Abs were
revealed using, as chromogen, DAB, observed as a dark
brown colour. Once the reaction was stopped, epithelial
layers were stretched to make them as ﬂat as possible,
immunomount solution was added, and the slides were
coverslipped and analysed using a Carl Zeiss microscope.
At least 20 different ﬁelds were evaluated for each differ
ent portion of epithelial sheet obtained.

Hybrid capture system to identify the group
of high-risk HPV
A small piece of the cervix sample was placed in Digene
hybrid capture transport medium (Digene Diagnostics

Inc., Silver Springs, MD), following the manufacturer’s
instructions. Samples were then incubated in denaturation
reagent to produce single stranded DNA. The HPV RNA
probe cocktails for high risk HPV were added with either
control or test samples and allowed to hybridize at 65�
for 1 hr. The hybridized DNA RNA was then placed into
tubes coated with anti hybrid immunoglobulin, and
immobilized hybrids were then incubated with alkaline
phophatase tagged Abs. After incubation and subsequent
washing, the Lumi Phos detection reagent was added to
each tube, the tubes were incubated for 30 min at room
temperature, after which they were read using a lumino
meter. Each set of samples was run with the positive and
negative controls provided by the hybrid capture kit.
Results are expressed as relative light units (RLU) and
represent the mean of triplicate readings for each sample.
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Data analysis
Mean values and standard deviations were calculated for
numerical variables. The Mann Whitney test was per
formed to compare the DC density with positive markers
between study groups (HPV+ and HPV– controls). All
results were viewed as signiﬁcant if P < 0�05. Bivariate
correlation between DC density with the age of patients,
and DC density with the study group, were analysed
using Spearman’s rho non parametric test. In order to
evaluate both independent variables as predictors of DC
density, we used a linear regression by enter method. The
data were analysed using the software Statistics Profes
sional Social Science (SPSS�) version 10 for Windows�.
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Results
Histology of conventional tissue sections and
identiﬁcation of MHC-CII (DR)+ cells in normal
cervix
We ﬁrst evaluated the normal histological appearance of
the cervix region, especially around the TZ. In Fig. 1(a),
the epithelium (upper part) is readily distinguishable
from the stroma (lower part). Likewise, cells labelled for
MHC CII are clearly apparent, especially in the basal cells
of the epithelium (arrows in Fig. 1b,c). Occasionally, the
cut permits that one of these MHC CII+ cells might
resemble a DC (arrow in Fig. 1c), although their mor
phology in the sections does not allow such a precise dis
tinction to be made.

Cervical epithelial sheets as an appropiate tool
for in situ assessment of genital tract DC
By means of enzymatic treatment, we successfully adapted,
to freshly taken cervix samples, the approach of epidermal
sheet separation. The epithelial layers obtained from cervix

Figure 1. Basic histology and major histocompatibility complex
(MHC) CII (DR)+ cells in conventional tissue sections of human
papilloma virus (HPV) negative cervix. Cervix samples obtained from
high risk HPV negative women were frozen, and conventional tissue
sections were stained with haematoxylin (a) and with a monoclonal
antibody to MHC II (DR) (b, c). The epithelium is clearly distinguish
able from the underlying stroma (a; ·10 magniﬁcation). In this
section, bound MHC II antibody was revealed with peroxidase and
diaminobenzidine (DAB), as a brown colour (b, c). Brown MHC
CII+ cells are clearly evident around the lower stratum of the cervix
epithelium (arrows in panel b; ·20 magniﬁcation). In some
of these cells, a dendritic appearance was revealed (arrow in panel c;
·40 magniﬁcation).

tissue upon this treatment were, indeed, useful for exam
ining the DC morphology. Indeed, by using this approach
it was possible to evaluate not only individual DC, each

Figure 2. Cervical epithelial sheets reveal cells with prominent dend
ritic morphology and a regular pattern of distribution. Fresh cervix
biopsies were subjected to enzymatic treatment to separate epithelial
layers in order to perform immunohistochemistry with antibodies to
CD1a (a, b, d) and major histocompatibility complex (MHC) CII
(DR) (c). A dense network of strongly positive cells with notorious
dendritic appearance is clearly revealed in epithelial sheets from cer
vix tissue. Likewise, a regular pattern of distribution is readily
observable (a). Not only the morphology of individual, complete
cells can be assessed, but also single dendrites in each DC (c and d,
arrows). (a) ·10 magniﬁcation; (b) and (c) ·40 magniﬁcation;
(d) ·100 magniﬁcation.

one complete, but also the extension and the arrangements
of single dendrites in a given cell (arrows in Fig. 2c,d).
This was also a very convenient means of assessing whe
ther DC showed any peculiar pattern of distribution in the
cervix, which would not be possible to determine using
conventional tissue sectioning. For instance, a dense net
work of DC in a planar like arrangement was revealed
with each of the Abs used (Fig. 2a; CD1a staining).
Indeed, the DC topography shown with these three mark
ers revealed that DC are not randomly scattered along the
cervix epithelium, but instead are regularly distributed
(Fig. 2a), like DC in the skin. In fact, both the morphol
ogy and the regular pattern of distribution resembled very
much that of the epidermal Langerhan’s cells (LC), and
was manifested through each of the three Abs used: DR,
CD1a and Langerin (Fig. 3a c). However, as in the skin,
cervical DC were more obviously dendritic when revealed
with MHC II DR and CD1a than with Langerin, which,
perhaps owing to the staining of the soma, did not pro
vide such a prominent dendritic appearance, but instead
delineated well the DC body (Fig. 3c).

Figure 3. Dendritic cells (DC) in cervical epithelial sheets of human
papilloma virus negative (HPV ) and human papilloma virus posit
ive (HPV+) patients. Epithelial layers of cervix samples obtained
from HPV and HPV+ cervical intraepithelial neoplasia I (CIN I)
patients were used to assess the morphology, distribution and fre
quency of DC with antibodies to CD1a (a and d), major histocom
patibility complex class II (MHC II) (DR) (b and e) and Langerin
(c and f); (a) (f), ·40 magniﬁcation. Apart from quantitative and
morphological changes, the regular pattern of DC distribution was
also modiﬁed in the HPV infected samples (d f). The morphology
of Langerin+ cells was clearly altered in HPV+ sheets (f) compared
with HPV samples (c).

patients (CIN I stage) provided a very strong signal for
high risk HPV in the luminometer readings, and only a
few (four) gave a weak, but positive, signal (Fig. 4, black
bars). It was also evident that for the samples taken from
control patients, readings were clearly negative in this sys
tem (Fig. 4, white bars), thus correlating well with all the
criteria (clinical, laboratory tests and cyto pathology) used
for preselecting both groups.

Samples from HPV+ cervix express, in situ, abundant
L1 protein of HPV16 and koilocytosis
Frozen sections of fresh cervix biopsies from HPV+, CIN
I grouped women, were subjected to immunohistochem
istry using Abs to L1 of high risk HPV16. Numerous epi
thelial cells from these HPV+ samples were found to
strongly express L1 HPV16 protein, and the positivity
increased towards the lumen Fig. 5(b d). Basal cells of
the epithelium, at the lower stratum, and also cells in the
underlying stroma, were L1 negative (Fig. 5b). The cells
termed koilocytes were also evident in the tissue
(arrows in Fig. 5c,d), thus verifying the cellular manifesta
tions typical of these early epithelial lesions during HPV
infection.

HPV+ CIN-I versus HPV– (control) samples

Reduction of DC frequency in cervix layers
of HPV+ patients

By means of the hybrid capture method, a small portion
of freshly obtained tissue was used to assess the presence
of high risk HPV (nine types of mucotropic HPV). It was
clear that most samples of the clinically preselected

Once the immunolabelling of DC in cervical epithelial
sheets had been established, we performed a comparison
between DC in epithelial layers obtained from control,
HPV negative cervix tissue and samples from high risk
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Figure 4. Cervical intraepithelial neoplasia (CIN) I samples, but not
control samples, are positive for high risk human papilloma virus
(HPV). Fresh tissue samples from cervix were evaluated for the pres
ence of the high risk HPV by using the hybrid capture system.
Women (n 16) were ﬁrst preselected using multiple criteria (clin
ical, laboratory tests and cyto pathology), and samples were tested
for the presence of DNA of the high risk HPV group. Control sam
ples were from hysterectomy performed for benign conditions in
n 5 women, showing normal results using the same clinical and
cyto pathology criteria. Control samples (left side of the ﬁgure) were
all negative for the presence of high risk HPV, while the 16 CIN I
preselected samples were positive for high risk HPV (right side of
the ﬁgure). Most CIN I samples were strongly positive. The results
are expressed as relative light units (RLU) and represent the mean of
triplicate readings for each sample.
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Figure 6. High risk human papilloma virus (HPV) infection reduces
the number of dendritic cells (DC) in human cervix. Epithelial layers
from freshly obtained cervix samples were used to quantify the DC
frequency per area in all tissue samples obtained from both control
HPV (white bars) and HPV+ (grey bars) women. Assessment was
performed for each of the three markers [major histocompatibility
complex class II (MHC II), CD1a and Langerin], and the results rep
resent the mean value plus standard error of all quantiﬁcations per
formed, at least in triplicate, on each sample from all the women
examined. (*P < 0 001).

tion between the DC frequency with the age of patients
was low and similar for all markers, at � 0�40. The corre
lation between the DC density with the variable study
groups was 0�59 for MHC II, 0�61 for CD1a and 0�51 for
Langerin. Standardized coefﬁcients obtained with linear
regression were as follows: 0�64 for MHC II when group
variable was the predictor, and 0�02 for age; 0�69 for
CD1a with group variable as the predictor, and 0�01 for
age; and 0�51 for Langerin with group variable as the pre
dictor, and 0�12 for age.

Altered morphology of Langerin+ DC in HPV+ cervix
Figure 5. L1 protein expression and koilocytosis in human papil
loma virus (HPV)+ cervical intraepithelial neoplasia I (CIN I) cervix.
Cervix samples from CIN I grouped women were subjected to im
munohistochemistry using antibodies to the L1 protein of HPV16.
Abundant cells in the tissue strongly express the L1 protein, especi
ally towards the upper stratum of the epithelium (b d), while basal
epithelial cells and stromal cells are negative (b). Likewise, koilocyto
sis, a typical cytopathic response of early infection, is easily observed
in the HPV infected epithelium (arrows in c and d). (a) HPV+ epi
thelium labelled with an irrelevant isotype matched control anti
body. (a) ·10 magniﬁcation; (b) ·20 magniﬁcation; (c) and (d) ·100
magniﬁcation.

HPV+ women. As shown in Fig. 3(d f) and Fig. 6, DC
were less numerous in samples prepared from HPV+
women than in epithelial sheets obtained from non infec
ted cervix samples. In fact, at � 50%, DC reduction was
similar for all three markers (Fig. 6). Statistically signiﬁ
cant differences between the HPV– and the HPV+ groups
were found for all three markers examined. The correla

Langerin staining in epithelial sheets from cervix depicted
mainly the cell soma of DC, rather than providing a
clearly delineated dendritic morphology like that observed
with MHC II+ or CD1a+ DC. It was interesting therefore
to ﬁnd that Langerin staining revealed a prominent dend
ritic appearance (Fig. 3f) only in HPV+ samples, perhaps
indicating signs of DC activation in situ.

Discussion
Although there are a number of reports of DC in the
HPV infected human female genital tract, especially in
the cervix, these appear to be contradictory because some
describe no changes, some have found a decreased num
ber of DC and others have seen increased DC num
bers.18–21 Various reasons have been suggested for these
discrepancies.
(1) The precise histological locations where the biopsies
were taken might have been different.

(2) The disease stages of the HPV infected samples exam
ined may have been different.
(3) Most studies used only single, but different, markers
to identify DC: most used S 100; others used were
MHC CII22 and ATPase. Fewer have used CD1a,23
and we know of no studies that have used the Lang
erhans’ cell restricted marker, Langerin. Furthermore,
to the best of our knowledge there are no descriptions
of these three DC markers (MHC CII, CD1a, Lang
erin) evaluated together.
(4) The methodological approach used to perform these
evaluations should also be taken into account. As far
as we know, researchers have used mostly conven
tional tissue sections not only to identify DC, but also
to quantify them. However, we believe that for accu
rately assessing DC, at least three different criteria
(evident dendritic morphology, topographic distribu
tion within tissues and, perhaps more important for
these studies, DC quantiﬁcation) should be used. The
use of cervical epithelial sheets is more appropriate
than conventional tissue sectioning. We believe this
because, if DC are arranged in a planar like layer
(which they seem to be in mucosae and skin) in a
rather uniform distribution, only those parts of a DC
body traversed by the cut will be visualized during
immunolabelling. In contrast, epithelial sheets, by
providing an en face view of each complete cell, are a
very convenient means of simultaneously assessing
morphology (even at the level of a single cell and a
single dendrite, arrows in Fig. 2c,d), the pattern of
DC distribution and optimizing their quantiﬁcation
per tissue area. Moreover, it is also important to con
sider that cervical epithelial sheets, not undergoing
the process of parafﬁn embedding and not being fro
zen, but freshly prepared and immediately ﬁxed, are
more likely to provide a closer approximation of how
the tissue and the cells might be in reality. In fact, it
was readily observed that DC in the cervix epithelium
are not randomly scattered, and they do not seem to
be clustered in certain areas along the epithelium.
Instead, they were found to exhibit a rather regular
and uniform pattern of distribution, resembling very
much that of cutaneous LC in epidermal sheets
(Fig. 2a). Moreover, this regular pattern of distribu
tion was revealed with all of the three DC markers
used (CII, CD1a and Langerin), although with differ
ent morphological appearances, especially for Lang
erin+ cells.
We are interested in studying in situ the local, regional
immune responses in the female genital tract, especially
during the development of the early premalignant stages
of HPV infection. We have therefore chosen to initiate
these studies with women positive for the group of vir
uses associated with cervical carcinoma
the high risk

HPV group and we chose to study only patients categ
orized as having CIN I. Although this stage represents a
premalignant lesion appearing early during HPV infec
tion, these lesions express viral proteins. Usually these
lesions will be associated with peculiar cellular manifesta
tions, termed koilocytosis (a cytopathic consequence of
the early viral infection), which appear in the TZ. Indeed,
koilocytes were readily observed in the cervical epithelium
of our HPV+ samples examined (arrows in Fig. 5c,d).
Furthermore, positivity was also manifested for the L1
viral protein (but not for the E7 viral protein; data not
shown) (Fig. 5) in the epithelium of seven of the samples
examined, being stronger towards the lumen. However, in
these same samples in which a strong positivity for the
viral protein L1 was revealed, no labelled cells exhibited
an apparent dendritic morphology (Fig. 5b). Furthermore,
no L1 positive cells were seen in the area where MHC II+
cells were located (Figs 1b and 5b). This suggests that
high risk HPV infection, at least in an early premalignant
stage, such as CIN I, does not reach or target these local
APC; more detailed research is needed to elucidate this.
In fact, it is known that mature HPV virions are pro
duced at the most external cell layers of the cervix and
released into the lumen. HPV progeny are shed into the
environment with epithelial squamae, therefore preclu
ding useful contacts with cells of the local or the systemic
immune system, somehow making the host immunologi
cally unaware of the infection.6,7
We do not have a precise explanation for the decrease
of DC found in the HPV infected cervix, although several
possibilities exist, including: reduction of the DC (or their
immediate precursors) colonizing this area; increased exit
ing or trafﬁc of the normally resident cells; or promoted
DC death. We believe that the last possibility, although
possible, is less likely to occur because HPV is known to
induce proliferation rather than cell death, at least in epi
thelial cells.6 We are currently examining these possibilit
ies. The mean age of the HPV+ CIN I group was
32�5 years and that of the control HPV– hysterectomy
group was 42�5 years. Because of ethical constraints it was
not feasible to biopsy healthy women of younger age with
no medical justiﬁcation. However, the correlation between
DC density and age was low and similar for all markers.
Additionally, the standardized coefﬁcients of multivariant
analysis indicate that the observed changes in DC fre
quency were not related to age, but to the HPV infection
status. Moreover, in another epithelium, such as the skin,
DC frequency has been reported to be substantially
reduced in the elderly,24 not increased. If there were any
parallel between these two epithelia, the skin report indi
rectly supports our ﬁndings in the cervix because the
decreased DC frequency was found in the younger
(HPV+ CIN I), and not in the older (hysterectomy, con
trol), age group.

Regarding the potential meaning and consequences of
the low DC frequency found in the cervix samples of all
patients infected with high risk HPV, as DC are the most
peripheral sentinel cells of the immune system and are
crucial for delivering appropriately processed antigenic
information to T cells, this may represent one of many
viral subversion stratagems given that the three markers
used to identify the DC (MHC CII, CD1a and Langerin),
are all importantly involved in Ag capturing, processing
and presentation. Conceivably, a consequence of this
could be a more permissive microenvironment for the
HPV to initiate and establish infection within the regional
tissue. On the one hand, local DC deﬁciency is likely to
impede efﬁcient T cell recruitment into this microenvi
ronment. On the other hand, local DC deﬁcit might also
hamper the efﬁcient ferrying of Ag into regional lymph
nodes, thus further interfering with the development of
effective cytotoxic T cell responses. Another important
fact to consider is that not only the quantity of DC was
decreased in the HPV infected cervix; HPV might also
affect the early process of DC activation because, in these
same samples where MHC II+, CD1a+ and Langerin+ cells
were readily identiﬁed, we were unable to demonstrate
DC expressing CD40 (not shown), a molecule well known
to be induced by different stimuli during the normal pro
cess of DC activation and maturation. It is thus intriguing
that precisely within the cervical tissue microenvironment
where the HPV infection naturally occurs, there are fewer
DC and those remaining might not be activated and may
not be actually infected. Viral infection during these early
stages (CIN I) might therefore interfere with establishing
a local tissue microenvironment appropriate to the subse
quent development of efﬁcacious T cell responses, pos
sibly facilitating, in this way, the progression of these
early lesions into carcinomas. According to some,6 HPV
infection might thus create a localized immunodeﬁcient
microenvironment, especially in the TZ. Perhaps all of
these different contributing factors may help to explain
the reports on the intriguing ﬁndings that apparently
many patients lack CTL reactivity, even after long periods
(months or years) of documented HPV infection.6,7 More
research is certainly required, ﬁrst in order to obtain a
better picture of the early responses of the local immune
system and the potential viral subversion strategies and,
second, to try to develop better therapeutic or prophylac
tic approaches for this cancer of infectious origin.
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